CGON - CG Oncology Inc. News

ANI Pharmaceuticals Plans To Appeal Judge Sheldon K. Rennie's Decision To Deny ANI's Post-Trial Moti

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced that Judge Sheldon K. R

CG Oncology Stock Gains 12% in Three Months: What's Driving It?

CGON climbs as cretostimogene nears a planned 2026 BLA filing, posts encouraging phase II data. It m

CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead

CG Oncology NASDAQ: CGON Chief Executive Officer Arthur outlined the company's upcoming clinical and

seekingalpha.com

CG Oncology, Inc. (CGON) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Tra

CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push

CG Oncology NASDAQ: CGON is focused on advancing cretostimogene, an oncolytic immunotherapy for non-

CG Oncology to Present at Upcoming Investor Conferences in June

DALLAS, May 28, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthu

CG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conference

CG Oncology NASDAQ: CGON executives used an RBC Capital Markets fireside chat to outline recent clin

SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder C

Patrick Hensley, MD and Daniel Joyce, MD, MS each received a grant up to $50,000.00 to support the d

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intraves

- High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the IT

CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears

CG Oncology NASDAQ: CGON executives said the company remains on track to complete a rolling biologic

seekingalpha.com

CG Oncology, Inc. (CGON) Presents at Bank of America Global Healthcare Conference 2026 Transcript

CG Oncology's Presence at American Urological Association (AUA) Annual Meeting Underscores its Stron

-First results from CORE-008 Cohort CX Phase 2 Trial evaluating intravesical combination therapy in

CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings

CG Oncology (NASDAQ:CGON) reported mixed results for the first quarter on Friday.

CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue Estimates

CG Oncology, Inc. (CGON) came out with a quarterly loss of $0.71 per share versus the Zacks Consensu

CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates

DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today reported financial r

Wall Street Analysts Think CG Oncology, Inc. (CGON) Could Surge 29.78%: Read This Before Placing a B

The consensus price target hints at a 29.8% upside potential for CG Oncology, Inc. (CGON). While emp

CG Oncology to Present at Upcoming Investor Conferences in May

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthu

CG Oncology, Inc. (CGON) Upgraded to Buy: Here's What You Should Know

CG Oncology, Inc. (CGON) might move higher on growing optimism about its earnings prospects, which i

CGON Stock Up 60.8% in Six Months: Here's What You Need to Know

CG Oncology stock surges as early phase III data, strong bladder cancer results and a $900M cash cus

defenseworld.net

CG Oncology, Inc. $CGON Stake Lifted by JPMorgan Chase & Co.

JPMorgan Chase and Co. boosted its stake in CG Oncology, Inc. (NASDAQ: CGON) by 321.3% during the un

fool.com

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know

Kynam Capital sold 1,059,375 shares of CG Oncology in the fourth quarter; the estimated trade size w

Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January

12 Health Care Stocks Moving In Friday's Intraday Session

CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday